Patents by Inventor Rasmus Rojkjaer

Rasmus Rojkjaer has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Use of Factor VII Polypeptides for Neuroprotection
    Publication number: 20090221484
    Abstract: New methods and compositions for providing neuroprotection in gyrencephalic mammals comprising a neuroprotective dose of Factor Vila or a neuroprotective Factor Vila equivalent are provided.
    Type: Application
    Filed: October 10, 2006
    Publication date: September 3, 2009
    Applicants: Novo Nordisk A/S, The Trustees of The University of Pennsylvania
    Inventors: Rasmus Rojkjaer, Douglas Smith
  • Use of Factor VIIa for the Treatment of Burn Trauma
    Publication number: 20090053193
    Abstract: The invention relates to the use of Factor VIIa or a Factor VIIa equivalent for the manufacture of a medicament for treatment of burn trauma.
    Type: Application
    Filed: May 11, 2005
    Publication date: February 26, 2009
    Applicant: Novo Nordisk HealthCare A/G
    Inventors: Par Johannson, Rasmus Rojkjaer
  • Pharmaceutical Composition Comprising Factor VII Polypeptides and Protein C Inhibitors
    Publication number: 20080102064
    Abstract: The present invention relates to a composition comprising factor VII or a factor VII-related polypeptide and a protein C inhibitor, and the use thereof for treating bleeding episodes.
    Type: Application
    Filed: October 25, 2007
    Publication date: May 1, 2008
    Applicant: Novo Nordisk HealthCare A/G
    Inventor: Rasmus Rojkjaer
  • Pharmaceutical Composition Comprising Factor VII Polypeptides And Thrombomodulin Polypeptides
    Publication number: 20080075709
    Abstract: The present invention relates to a composition comprising factor VII or a factor VII-related polypeptide and thrombomodulin or a thrombomodulin-related polypeptide, and the use thereof for treating bleeding episodes.
    Type: Application
    Filed: October 4, 2007
    Publication date: March 27, 2008
    Applicant: Novo Nordisk HealthCare A/G
    Inventor: Rasmus Rojkjaer
  • Combined Use of Factor VII Polypeptides and Factor VIII Polypeptides
    Publication number: 20080076702
    Abstract: The invention concerns a pharmaceutical preparation comprising a factor VII or factor VII-related polypeptide and a factor VIII or factor VIII-related polypeptide. The invention also concerns use of a factor VII or factor VII-related polypeptide and a factor VIII or factor VIII-related polypeptide for manufacture of a medicament for pharmaceutical use as well as methods for prevention or treatment of bleeding episodes in subjects.
    Type: Application
    Filed: October 4, 2007
    Publication date: March 27, 2008
    Applicant: Novo Nordisk HealthCare A/G
    Inventors: Jens Knudsen, Ulla Hedner, Rasmus Rojkjaer
  • Combined Use of Factor VII Polypeptides and Factor IX Polypeptides
    Publication number: 20080075711
    Abstract: The invention concerns a pharmaceutical preparation comprising a factor VII or factor VII-related polypeptide and a factor IX or factor IX-related polypeptide. The invention also concerns use of a factor VII or factor VII-related polypeptide and a factor IX or factor IX-related polypeptide for manufacture of a medicament for pharmaceutical use as well as methods for prevention or treatment of bleeding episodes in subjects.
    Type: Application
    Filed: October 4, 2007
    Publication date: March 27, 2008
    Applicant: Novo Nordisk HealthCare A/G
    Inventors: Jens Knudsen, Ulla Hedner, Rasmus Rojkjaer
  • Pharmaceutical Composition Comprising Factor VII Polypeptides and TAFI Polypeptides
    Publication number: 20080069810
    Abstract: The present invention relates to a composition comprising factor VII or a factor VII-related polypeptide, and TAFI or a TAFI-related polypeptide, and the use thereof for treating bleeding episodes.
    Type: Application
    Filed: September 14, 2007
    Publication date: March 20, 2008
    Applicant: Novo Nordisk HealthCare A/G
    Inventor: Rasmus Rojkjaer
  • Pharmaceutical Compositions Comprising Factor VII Polypeptides and Factor XI Polypeptides
    Publication number: 20080058266
    Abstract: Compositions comprising a factor VII or factor VII-related polypeptide and a factor XI or factor XI-related polypeptide, kits comprising the same, and methods of using such compositions (e.g.
    Type: Application
    Filed: September 5, 2007
    Publication date: March 6, 2008
    Applicant: Novo Nordisk HealthCare A/G
    Inventor: Rasmus Rojkjaer
  • Pharmaceutical Composition Comprising Factor VII Polypeptides and Protein S Inhibitors
    Publication number: 20080057059
    Abstract: The present invention relates to a composition comprising factor VII or a factor VII-related polypeptide and a protein S inhibitor, and the use thereof for treating bleeding episodes.
    Type: Application
    Filed: September 5, 2007
    Publication date: March 6, 2008
    Applicant: Novo Nordisk HealthCare A/G
    Inventor: Rasmus Rojkjaer
  • PHARMACEUTICAL COMPOSITION COMPRISING A FACTOR VIIa AND A FACTOR XIII
    Publication number: 20070280920
    Abstract: The present invention relates to the use of a factor VIIa and a factor XIII in the treatment or prophylaxis of bleeding episodes.
    Type: Application
    Filed: May 30, 2007
    Publication date: December 6, 2007
    Applicant: Novo Nordisk HealthCare A/G
    Inventors: Lars Petersen, Ulla Hedner, Rasmus Rojkjaer
  • Pharmaceutical composition comprising factor VII polypeptides and TAFI polypeptides
    Patent number: 7291587
    Abstract: The present invention relates to a composition comprising factor VII or a factor VII-related polypeptide, and TAFI or a TAFI-related polypeptide, and the use thereof for treating bleeding episodes.
    Type: Grant
    Filed: November 8, 2002
    Date of Patent: November 6, 2007
    Assignee: Novo Nordisk HealthCare A/G
    Inventor: Rasmus Rojkjaer
  • Pharmaceutical Composition Comprising Factor VII Polypeptides and PAI-1 Polypeptide
    Publication number: 20070219135
    Abstract: The present invention relates to a composition comprising factor VII or a factor VII-related polypeptide, and PAI-1 or a PAI-1-related polypeptide, and the use thereof for treating bleeding episodes.
    Type: Application
    Filed: May 31, 2007
    Publication date: September 20, 2007
    Applicant: Novo Nordisk HealthCare A/G
    Inventor: Rasmus Rojkjaer
  • Pharmaceutical compositions comprising factor VII polypeptides and factor XI polypeptides
    Publication number: 20070027077
    Abstract: Compositions comprising a factor VII or factor VII-related polypeptide and a factor XI or factor XI-related polypeptide, kits comprising the same, and methods of using such compositions (e.g.
    Type: Application
    Filed: March 1, 2005
    Publication date: February 1, 2007
    Applicant: Novo Nordisk A/S
    Inventor: Rasmus Rojkjaer
  • Pharmaceutical composition comprising a factor VII polypeptide and epsilon-aminocaproic acid
    Publication number: 20060293241
    Abstract: The present invention relates to compositions or kits comprising factor VII or a factor VII-related polypeptide and epsilon-aminocaproic acid, and the use thereof for the treatment of bleeding episodes or enhancement of hemostasis.
    Type: Application
    Filed: August 28, 2006
    Publication date: December 28, 2006
    Applicant: Novo Nordisk HealthCare A/G
    Inventor: Rasmus Rojkjær
  • Combined use of factor VII polypeptides and factor VIII polypeptides
    Publication number: 20060276398
    Abstract: The invention concerns a pharmaceutical preparation comprising a factor VII or factor VII-related polypeptide and a factor VIII or factor VIII-related polypeptide. The invention also concerns use of a factor VII or factor VII-related polypeptide and a factor VIII or factor VIII-related polypeptide for manufacture of a medicament for pharmaceutical use as well as methods for prevention or treatment of bleeding episodes in subjects.
    Type: Application
    Filed: July 25, 2006
    Publication date: December 7, 2006
    Applicant: Novo Nordisk HealthCare A/G
    Inventors: Jens Knudsen, Ulla Hedner, Rasmus Rojkjaer
  • Pharmaceutical composition comprising factor VII polypeptides and factor V polypeptides
    Patent number: 7125846
    Abstract: The present invention relates to a composition comprising factor VII or a factor VII-related polypeptide, and factor V or a factor V-related polypeptide, and the use thereof for treating bleeding episodes.
    Type: Grant
    Filed: November 8, 2002
    Date of Patent: October 24, 2006
    Assignee: Novo Nordisk HealthCare A/G
    Inventor: Rasmus Rojkjaer
  • Combined use of factor VII polypeptides and factor IX polypeptides
    Publication number: 20060211621
    Abstract: The invention concerns a pharmaceutical preparation comprising a factor VII or factor VII-related polypeptide and a factor IX or factor IX-related polypeptide. The invention also concerns use of a factor VII or factor VII-related polypeptide and a factor IX or factor IX-related polypeptide for manufacture of a medicament for pharmaceutical use as well as methods for prevention or treatment of bleeding episodes in subjects.
    Type: Application
    Filed: May 18, 2006
    Publication date: September 21, 2006
    Applicant: Novo Nordisk HealthCare A/G
    Inventors: Jens Knudsen, Ulla Hedner, Rasmus Rojkjaer
  • Pharmaceutical composition comprising a factor VIIa and a factor XIII
    Publication number: 20060199766
    Abstract: The present invention relates to the use of a factor VIIa and a factor XIII in the treatment or pro-phylaxis of bleeding episodes.
    Type: Application
    Filed: March 28, 2006
    Publication date: September 7, 2006
    Applicant: Novo Nordisk HealthCare A/G
    Inventors: Lars Petersen, Ulla Hedner, Rasmus Rojkjaer
  • Pharmaceutical composition comprising factor VII polypeptides and alpha2-antiplasmin polypeptides
    Patent number: 7078479
    Abstract: The present invention relates to a composition comprising factor VII or a factor VII-related polypeptide and alpha2-antiplasmin or an alpha2-antiplasmin-related polypeptide, and the use thereof for treating bleeding episodes.
    Type: Grant
    Filed: November 4, 2002
    Date of Patent: July 18, 2006
    Assignee: Novo Nordisk HealthCare A/G
    Inventor: Rasmus Rojkjaer
  • Pharmaceutical composition comprising factor VII polypeptide and PAI-1 polypeptide
    Publication number: 20060030531
    Abstract: The present invention relates to a composition comprising factor VII or a factor VII-related polypeptide, and PAI-1 or a PAI-1-related polypeptide, and the use thereof for treating bleeding episodes.
    Type: Application
    Filed: October 11, 2005
    Publication date: February 9, 2006
    Applicant: Novo Nordisk HealthCare A/G
    Inventor: Rasmus Rojkjaer